Dr. Luc Berghman Recognized at the 2017 Patent and Innovations Award Luncheon

Brett L. Cornwell, Associate Vice Chancellor for Research Commercialization, Dr. Luc Berghman, and Dr. Glen A. Laine, Vice President for Research

From L to R: Brett L. Cornwell, Associate Vice Chancellor for Research Commercialization, Dr. Luc Berghman, and Dr. Glen A. Laine, Vice President for Research

Dr. Luc Berghman was recognized for his accomplishments during the 2017 Patent and Innovations Award Luncheon which was held on Thursday, May 4, 2017. This event was put on by the Texas A&M University System Office of Technology Commercialization and spotlights the patents and PVP’s issued to TAMU faculty during 2016.  The patent of which Dr. Berghman was a co-inventor describes compositions and methods of enhancing immune responses against Influenza A and methods of reducing morbidity associated with an Influenza A infection in chickens

  • Patent # US 9,226,957; 5, 2016. Compositions and methods of enhancing immune responses
    Inventors: Bottje, W., Hargis, B., Berghman, L., Kwon, Y.M., Cole, K., Cox, M., and S. Layton.
    Abstract: Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated with an Influenza A infection. Methods of enhancing an immune response to a vaccine vector by expressing a polypeptide of CD154 capable of binding CD40 are also disclosed. Methods of developing a bacterial vaccine vector are disclosed. Methods of generating scar-less site-specific mutations in a bacterium are also disclosed.

Congratulations Dr. Berghman!

 

 

Comments are closed.